Government awards Delhi patient ₹67 lakh for faulty J&J implant | Latest News Delhi - Hindustan Times
close_game
close_game

Government awards Delhi patient 67 lakh for faulty J&J implant

Hindustan Times, New Delhi | By
Apr 05, 2019 07:49 AM IST

The Central Drugs Standard Control Organisation (CDSCO), India’s regulatory body for pharmaceuticals and medical devices, has directed J&J to pay the compensation amount to the Delhi patient within 30 days from the date receipt of the order, which was sent out a week ago.

The government has awarded 67 lakh as compensation to a Delhi resident who had received a faulty Johnson & Johnson’s (J&J) hip implant before August 2010, according to people familiar with the matter.

At least 200 applications are under consideration by state-level committees for compensation from patients who received the faulty Articular Surface Replacement (ASR) hip implant in India.(REUTERS/Representative Image)
At least 200 applications are under consideration by state-level committees for compensation from patients who received the faulty Articular Surface Replacement (ASR) hip implant in India.(REUTERS/Representative Image)

The Central Drugs Standard Control Organisation (CDSCO), India’s regulatory body for pharmaceuticals and medical devices, has directed J&J to pay the compensation amount to the Delhi patient within 30 days from the date receipt of the order, which was sent out a week ago.

Hindustan Times - your fastest source for breaking news! Read now.

“The orders have been issued,” confirmed Dr S Eswara Reddy, drug controller general of India (DCGI).

Ten patients are being considered for compensation in Delhi, said Delhi government officials.

The company has to submit a receipt from the patient that the compensation has been paid to CDSCO within a month.

At least 200 applications are under consideration by state-level committees for compensation from patients who received the faulty Articular Surface Replacement (ASR) hip implant in India.

The faulty ASR hip implants manufactured by DePuy International Limited, a subsidiary of J&J Pvt Ltd, were recalled in 2010 globally with complaints of more than usual revision surgeries because of complications such as metal leaching and infections, among others.

The health ministry then set up an 11-member committee on February 7, 2017, to investigate patient complaints of adverse events against the implant. The report was submitted in February 2018 and had recommended a base amount of 20 lakh.

Based on the recommendations, the government constituted a central expert committee under the chairmanship of Dr RK Arya, director, Sports Injury Centre of Safdarjung Hospital, to determine the quantum of compensation.

The compensation amount was to be calculated on a case-to-case basis depending on the age and the level of disability of the person, with younger people with higher disability getting the maximum compensation.

All states were asked to form a state-level committee, to track and verify eligible patients, and to come up with an amount on the basis of the central committee’s formula.

The first compensation of 75 lakh was awarded to a patient in March this year.

A J&J spokesperson said, “Johnson & Johnson Private Limited remains committed to providing assistance, including appropriate compensation within an established framework, to ASR patients in India who have undergone revision surgery. The formula for compensation needs to be within a fully transparent framework arrived at through due process. As the matter is sub judice, we won’t be able to further comment.”

Unveiling 'Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!
SHARE THIS ARTICLE ON
Share this article
  • ABOUT THE AUTHOR
    author-default-90x90

    Anonna Dutt is a health reporter at Hindustan Times. She reports on Delhi government’s health policies, hospitals in Delhi, and health-related feature stories.

SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On